Niraparib as maintenance therapy in a patient with ovarian cancer and brain metastases

Ovarian cancer is the second the most common gynaecological malignancy in developed countries. 70% of patients relapse in the first 3 years following debulking surgery and first-line chemotherapy. Niraparib is a poly adenosine diphosphate ribose polymerase inhibitor which uses the concept of synthet...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMJ Case Rep
Main Authors: Gray, Simon, Khor, Xiao Ying, Yiannakis, Dennis
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2019
Fag:
Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation)
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6721186/
https://ncbi.nlm.nih.gov/pubmed/31466953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2019-230738
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker